Mid 2015, a Drug Price Policy was introduced in China, which has been spreading throughout the healthcare system and affecting the medication procurement systems. This article will discuss how the current drug procurement works in China, and what the implications and expected trends of the new policy are for the pharmaceutical pricing market.
Home > pricing
In two previous articles we have described and commented on two major influences on today’s Medical Device market in Europe. In this blog article, Helgert Van Raamt reflects upon the impact of regulation and new economical realities on medical devices innovation and pricing.
DRG’s and their effect on Medical Device Introduction, Reimbursement and the increasing medical professional resistance to new devices. This is the first blog in the series that identifies and discusses new obstacles in the marketing of Medical Devices, new hurdles, shifting roles and changing weights.
China is currently one of the most encouraging medical device markets in the world, ranking second and still growing according to the U.S. Commercial Service. The sheer size of the market alone, provides significant opportunities for medical device firms both domestic and international. Recent trends in the market have seen a slight decrease in MedTech […]
When viewing the global economic changes in the last few years, one of the most prominent trends observed are the changing healthcare systems in emerging economies. These emerging and ever changing healthcare markets have, for some time now, been one of TforG’s main areas of focus and continuous subject of study.